ADVERTISEMENT
ADVERTISEMENT
takeover
Drugmaker Teva Bids $40 Billion for Mylan
Bob Grant | Apr 23, 2015 | 2 min read
The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.
ADVERTISEMENT